BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 2012
View Archived Issues
Studies assess GS-9620-induced INF-alpha response and antiviral effects
Read More
Soligenix reports thermostability of vaccines using ThermoVax
Read More
U.S. university patents new candidate vaccine adjuvants
Read More
Novel potential vaccines reported for enteroviral infections
Read More
Phase I trial studies vandetanib combination therapy for brain cancer
Read More
Scientists in Europe uncover new recognition factor for HIV-1 entry
Read More
Phase I data available on antisense drug for ALS
Read More
IntelGenx and Redhill Biopharma launch pivotal trial of antimigraine product
Read More
Epizyme forms strategic partnership with Celgene
Read More
Shire reports topline data on drug for binge eating disorder
Read More
Galenea to receive funds from the Stanley Medical Research Institute
Read More
Phase I trial tests once-daily and intermittent INK-128 dosing
Read More
Continuation recommended for trial assessing whipworm egg therapy for Crohn's disease
Read More
Mount Sinai School of Medicine evaluates IGF-1 product in autism subtype
Read More
Omthera Pharmaceuticals reports topline results from EVOLVE study
Read More
Advanced Cell Technology clear to continue Stargardt's macular dystrophy trials
Read More
GlaxoSmithKline files application in Japan for ofatumumab
Read More
Novartis extends oncology discovery research collaboration
Read More
Dynavax files BLA for hepatitis B vaccine
Read More
FDA revises Victrelis label
Read More
Jazz Pharmaceuticals enters acquisition agreement
Read More
Amgen gives update on Xgeva sBLA
Read More
Investigation at Bionature yields novel candidate oncolytics
Read More
Novel DUB/FAF-X inhibitors presented
Read More
InterMune designs novel HCV NS3/NS4A inhibitors
Read More
German university announces novel candidate analgesics
Read More